Leon. Enabling nano now
It is estimated that over 80% of pharmaceutical pipeline API’s are poorly soluble in water. Leon’s ‘enabling nano now’ value proposition delivers novel, ready to use, validated, nano solutions that create value for partners and meets an unmet medical need for patients.
Its patented microjet reactor MJR® technology platform offers access to the next generation of SMART nano-particles™ and nano-formulated drugs, adding value at every stage of the chain from partners and payers to caregivers and patients.
At the forefront of innovation in the international pharmaceutical market, Leon is leading the way in supergenerics and high-barrier generics, revitalizing forgotten formulations and expediting APIs to deliver improved stability, increased solubility and enhanced bioavailability.